<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25623" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Necrotizing Fasciitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Wallace</surname>
            <given-names>Heather A.</given-names>
          </name>
          <aff>Old Dominion University, Johns Hopkins University, Baylor University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Perera</surname>
            <given-names>Thomas B.</given-names>
          </name>
          <aff>Hofstra Northwell</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Heather Wallace declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Thomas Perera declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>21</day>
          <month>2</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25623.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Necrotizing fasciitis is a subset of aggressive skin and soft tissue infections that cause muscle fascia and subcutaneous tissue necrosis. The infection typically travels along the fascial plane, which has a poor blood supply. The overlying tissues are initially unaffected, potentially delaying diagnosis and surgical intervention. The infectious process can rapidly spread, causing infection of the fascia and perifascial planes and secondary infection of the overlying and underlying skin, soft tissue, and muscle. This activity reviews the evaluation, treatment, and prognosis of necrotizing fasciitis and highlights the role of an interprofessional team in evaluating and improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the typical clinical presentation of a patient with necrotizing fasciitis.</p></list-item><list-item><p>Evaluate&#x000a0;how to manage a patient with suspected necrotizing fasciitis properly.</p></list-item><list-item><p>Assess&#x000a0;the complications associated with necrotizing fasciitis.</p></list-item><list-item><p>Communicate how enhanced coordination of the interprofessional team can lead to more rapid detection of necrotizing fasciitis, subsequently to more rapid intervention,&#x000a0;and better outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25623&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25623">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25623.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Necrotizing fasciitis is a subset of aggressive skin and soft tissue infections that cause muscle fascia and subcutaneous tissue necrosis. This infection typically travels along the fascial plane, which has a poor blood supply, leaving the overlying tissues initially unaffected, potentially delaying diagnosis and surgical intervention. The infectious process can rapidly spread, causing infection of the fascia and peri-fascial planes and causing a secondary infection of the overlying and underlying skin, soft tissue, and muscle.<xref ref-type="bibr" rid="article-25623.r1">[1]</xref><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmid" xlink:href="30185334">[2]</ext-link><xref ref-type="bibr" rid="article-25623.r2">[3]</xref>&#x000a0;Necrotizing fasciitis can occur post-surgery, invasive procedures, or even a minor procedure like phlebotomy. The causative bacteria are usually mixed but do produce gas. See <bold>Image.</bold>&#x000a0;Necrotizing Fasciitis.</p>
      </sec>
      <sec id="article-25623.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Necrotizing fasciitis is typically an acute process&#x000a0;that occurs rapidly over several days. In approximately 80% of cases, it is a direct sequela of bacterial infection introduced through a break in the skin&#x02019;s integrity. Gram-positive cocci, specifically strains of<italic toggle="yes">&#x000a0;Staphylococcus aureus&#x000a0;</italic>and&#x000a0;<italic toggle="yes">Streptococci</italic>&#x000a0;are responsible for most of these single-site source infections. Polymicrobial infections also occur because of a combination of gram-negative and anaerobic involvement.<xref ref-type="bibr" rid="article-25623.r3">[4]</xref><xref ref-type="bibr" rid="article-25623.r4">[5]</xref>&#x000a0;The majority of patients have diabetes and a history of alcoholism. Patients with liver cirrhosis are also prone to necrotizing fasciitis.</p>
      </sec>
      <sec id="article-25623.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Necrotizing fasciitis affects about 0.4 per 100,000 people annually in the United States. It is as common in some areas as&#x000a0;1 in every 100,000 people.<xref ref-type="bibr" rid="article-25623.r5">[6]</xref><xref ref-type="bibr" rid="article-25623.r6">[7]</xref></p>
      </sec>
      <sec id="article-25623.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The infection rapidly transits the muscle fascia. After several days, the overlying skin, which initially appears unaffected, will transition to an erythematous, reddish-purple to bluish-gray hue. The skin's texture will become indurated, swollen, shiny, and warm in temperature. At this stage, the skin is exquisitely tender to palpation and can also be painful and out of proportion to presenting symptoms. Skin breakdown will begin in 3 to 5 days and is accompanied by bullae and cutaneous gangrene. Pain is reduced in the affected area secondary to thrombosed small vessels and the destruction of the subcutaneous tissues' superficial nerves. Advanced stages of the infection are characterized by systemic symptoms such as fever, tachycardia, and sepsis.<xref ref-type="bibr" rid="article-25623.r7">[8]</xref>&#x000a0;Anaerobic bacteria mixed with aerobic organisms are commonly found in most soft tissue infections. Aerobic bacteria include Clostridium, Bacteroides, coliforms, proteus, klebsiella, peptostreptococcus, and Pseudomonas.&#x000a0;These organisms rapidly spread along with the subcutaneous tissues and deep fascial planes, causing vascular occlusion, tissue necrosis, and ischemia.</p>
      </sec>
      <sec id="article-25623.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>After debridement, tissue obtained from the operating room will usually show extensive superficial&#x000a0;fascial necrosis. The majority of small and medium-sized blood vessels will be thrombosed. Aggregates of neutrophils will be observed in the fascia and subcutaneous tissues. Small vessel vasculitis and extensive fat necrosis will also be evident. All the&#x000a0;glands in the&#x000a0;dermis and subcutaneous&#x000a0;tissues&#x000a0;will also be necrotic. Gram stain will show clusters of various types of microorganisms.</p>
      </sec>
      <sec id="article-25623.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Necrotizing infections are more commonly present with excruciating pain out of proportion to presenting symptoms and systemic septic signs than non-necrotizing infections. Physical findings of necrotizing soft tissue infections may include tenderness to palpation beyond the erythematous border, crepitus, and cellulitis. The presence of bullae, ecchymotic changes to the skin, and dysesthesia or paresthesia should also be treated as a necrotizing infection. Subcutaneous emphysema and crepitus are almost always present. Anesthesia may also be present in some areas due to injury to the nerve fibers. The infection can spread rapidly within hours; hence, suspicion should be high for necrotizing fasciitis in intense pain.</p>
      </sec>
      <sec id="article-25623.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Any rapidly progressing skin or soft tissue infection should be managed&#x000a0;aggressively due to the difficulty in differentiating non-necrotizing from necrotizing skin and soft tissue infections.<xref ref-type="bibr" rid="article-25623.r8">[9]</xref><xref ref-type="bibr" rid="article-25623.r9">[10]</xref><xref ref-type="bibr" rid="article-25623.r10">[11]</xref>&#x000a0;The Laboratory Risk Indicator for Necrotizing Infection Score was developed in a 2004 report to distinguish&#x000a0;necrotizing soft tissue infections (NSTIs) from other severe soft tissue infections. The scoring system is hinged on abnormalities in&#x000a0;6 independent variables:</p>
        <p>
<bold>C-reactive protein, mg/L</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Less than 150 (0)</p>
          </list-item>
          <list-item>
            <p>More than 150 (4)</p>
          </list-item>
        </list>
        <p>
<bold>Total white cell count (WBC), cells/mm</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>&#x000a0;Less than 15 (0)</p>
          </list-item>
          <list-item>
            <p>&#x000a0;15 to 25 (1)</p>
          </list-item>
          <list-item>
            <p>&#x000a0;More than 25 (2)</p>
          </list-item>
        </list>
        <p>
<bold>Hemoglobin, g/dl</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>&#x000a0;More than 13.5 (0)</p>
          </list-item>
          <list-item>
            <p>&#x000a0;11 to 13.5 (1)</p>
          </list-item>
          <list-item>
            <p>&#x000a0;Less than 11 (2)</p>
          </list-item>
        </list>
        <p>
<bold>Sodium, mmol/L</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>135 or greater&#x000a0; (0)</p>
          </list-item>
          <list-item>
            <p>Less than 135 (2)</p>
          </list-item>
        </list>
        <p>
<bold>Creatinine, mg/dL</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>1.6 or less (0)</p>
          </list-item>
          <list-item>
            <p>More than 1.6 (2)</p>
          </list-item>
        </list>
        <p>
<bold>Glucose, mg/dL</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>180 or less (0)</p>
          </list-item>
          <list-item>
            <p>More than 180 (1)</p>
          </list-item>
        </list>
        <p>A score of&#x000a0;6 has a positive predictive value of 92% and a negative predictive value of 96%. A score of&#x000a0;8 or greater represents a 75% risk of necrotizing infection. The diagnosis of NSTIs is still primarily clinical. Imaging may be useful in providing data when the diagnosis is uncertain. The most common plain film finding is similar to cellulitis with increased soft tissue thickness and opacity. Computed tomography has greater sensitivity than plain film in identifying necrotizing soft tissue infections. Plain X-rays have no value in the diagnosis. Sometimes, under local anesthesia, one may probe the area with a finger for signs of necrotizing tissue. In most cases, the necrotic tissue can be penetrated with little resistance. Aspiration and gram stain can also be done. B-mode color Doppler ultrasound can help in the early diagnosis of necrotizing fasciitis at the bedside. It should be understood that no lab or imaging test should delay surgical intervention.</p>
      </sec>
      <sec id="article-25623.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>These extremely ill patients should be transferred immediately to the intensive care unit. The sepsis causes refractory hypotension and diffuse capillary leak. Thus, the patient will need aggressive resuscitation with fluids and the use of inotropes to maintain blood pressure. The patient must be kept NPO (nothing by mouth) until seen by the surgeon. Nutrition is vital, but only after surgery has been completed. Enteral feedings should be started as soon as the patient is hemodynamically stable. The enteral feedings may help offset the massive negative protein balance due to catabolism.<xref ref-type="bibr" rid="article-25623.r4">[5]</xref><xref ref-type="bibr" rid="article-25623.r11">[12]</xref><xref ref-type="bibr" rid="article-25623.r12">[13]</xref></p>
        <p>Key concepts for treatment/management of skin and soft-tissue infections are:</p>
        <p>Early diagnosis and differentiation between necrotizing and non-necrotizing skin and soft tissue infections</p>
        <list list-type="order">
          <list-item>
            <p>The early launch of appropriate&#x000a0;empiric antibacterial coverage (wide-spectrum)</p>
          </list-item>
          <list-item>
            <p>Adequate control of infection sources, such as aggressive surgical intervention for abscess drainage and debridement of NSTIs</p>
          </list-item>
          <list-item>
            <p>Identification of infection-causing pathogens and applicable adjustment of antimicrobial coverage.</p>
          </list-item>
        </list>
        <p>Antimicrobial therapy for necrotizing fasciitis is&#x000a0;as follows:</p>
        <list list-type="order">
          <list-item>
            <p>Imipenem 1 g every 6 to 8 hours, daptomycin 6 mg/kg QD, and<bold>&#x000a0;</bold>clindamycin 600 mg to 900 mg&#x000a0;4 times daily.</p>
          </list-item>
          <list-item>
            <p>Piperacillin/tazobactam 3.375 g every 6 hours or 4.5 g every 8 hours,<bold>&#x000a0;</bold>daptomycin 6 mg/kg QD, and clindamycin 600 mg to 900 mg&#x000a0;4 times daily.</p>
          </list-item>
          <list-item>
            <p>Meropenem 1 g IV every 8 hours, vancomycin 15 to 20 mg/kg/dose every 8 to 12 hours, and&#x000a0;clindamycin 600 mg to 900 mg&#x000a0;4 times daily.</p>
          </list-item>
        </list>
        <p><bold>Surgery</bold>&#x000a0;</p>
        <p>The treatment of necrotizing fasciitis is surgery, and no time should be wasted calling for a surgical consult. The earlier the surgery is undertaken, the better the outcome. The surgery requires extensive,&#x000a0;wide debridement of all necrotic tissues. In some cases, a second-look surgery may also be required. Early surgery may help minimize tissue loss and eliminate the need for amputation of a gangrenous extremity. With wide debridement, the wounds must be left open and packed with wet gauze. Daily dressing changes are mandatory. The patient's recovery is faster as long as the necrotic tissue is removed. A great deal of surgical judgment is required when faced with normal-appearing tissue that is not necrotic. In most cases, the tissues should be removed if there is any doubt about viability. Hemodynamic stability is often restored once the necrotic tissue and pus are removed. The patient should be kept intubated and monitored in a critical care unit. In some patients, daily surgical debridement may be required. During the surgery, meticulous attention should be paid to hemostasis. Some patients may require repeat visits to the operating room to remove necrotic tissue.</p>
        <p>
<bold>Soft-tissue Reconstruction</bold>
</p>
        <p>The plastic surgeon should be consulted once all the necrotic tissue is removed and there is evidence of granulation tissue. In most cases, primary closure is not possible, and hence the plastic surgeon may be required to reconstruct the soft tissues and close the wound with a muscle flap. If there is no adequate natural skin available for a skin graft, then one may need to use artificial skin. Another method of treatment includes the use of hyperbaric oxygenation. While the literature does suggest this modality can be used, most of these patients are in the intensive care unit attached to a variety of medical equipment, thus making the journey to the hyperbaric oxygen therapy facility difficult. Hyperbaric oxygen therapy may be effective for small wounds, but there is no evidence that this therapy improves healing or prolongs life for large wounds. Finally, it should be noted that&#x000a0;hyperbaric&#x000a0;oxygen therapy&#x000a0;is an adjunctive treatment and not a substitute for surgical debridement. Hyperbaric oxygen&#x000a0;treatment may be useful when the patient is stable. Some data show that this treatment can help reduce mortality.&#x000a0;Hyperbaric oxygen is not a substitute for surgery but a complementary treatment.</p>
      </sec>
      <sec id="article-25623.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis for necrotizing fasciitis includes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cellulitis</p>
          </list-item>
          <list-item>
            <p>Epididymitis</p>
          </list-item>
          <list-item>
            <p>Gas gangrene</p>
          </list-item>
          <list-item>
            <p>Orchitis</p>
          </list-item>
          <list-item>
            <p>Testicular torsion</p>
          </list-item>
          <list-item>
            <p>Toxic shock syndrome</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25623.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Necrotizing fasciitis is a serious life-threatening infection with mortality rates ranging from 20 to 80%. Poor prognosis has been linked to certain streptococcal strains, advanced age, uncontrolled diabetes, state of immunosuppression, and delayed surgery. Even people who survive have a prolonged recovery with significant functional deficits.</p>
      </sec>
      <sec id="article-25623.s12" sec-type="Complications">
        <title>Complications</title>
        <p>The complications that can manifest with necrotizing fasciitis are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Multiorgan failure</p>
          </list-item>
          <list-item>
            <p>Septic shock</p>
          </list-item>
          <list-item>
            <p>Loss of extremity</p>
          </list-item>
          <list-item>
            <p>Severe scarring</p>
          </list-item>
          <list-item>
            <p>Toxic shock</p>
          </list-item>
          <list-item>
            <p>Death</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25623.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Necrotizing fasciitis is a life-threatening disorder that carries mortality ranging from 20% to 80%. Risk factors for adverse outcomes include advanced age, resistant organisms, delay in therapy, multiorgan failure, and infection site.</p>
      </sec>
      <sec id="article-25623.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Necrotizing is a life-threatening&#x000a0;disorder with a very&#x000a0;high mortality rate. Any delay in diagnosis or treatment usually results in a poor outcome. The disorder is best managed by a team of healthcare professionals that includes a urologist, a general surgeon, an infectious disease expert, an intensivist, a nephrologist,&#x000a0;intensive care unit nurses, and a radiologist. The role of the nurse and pharmacist is also of critical importance. The nurse is often the first to recognize that the patient is critically ill or in pain. Nurses should be knowledgeable about necrotizing fasciitis and consult the surgeon as soon as possible. The pharmacist must check the culture results and ensure the patient is on appropriate antibiotics. The patient should be kept NPO, hydrated, and immediately covered with broad-spectrum antibiotics. The pharmacist should check cultures and ensure that antibiotics are used to cover the offending organism. The stoma nurse should be consulted because many of these patients also need a fecal diversion to prevent contamination of the perineum. These patients are best managed in the&#x000a0;intensive care unit until signs of toxicity diminish. A wound care nurse is mandatory as most patients have large open wounds that require daily dressings for weeks or months. The wounds often need reconstructive surgery. Only through a systemic approach with close collaboration can the mortality of this condition be lowered.<xref ref-type="bibr" rid="article-25623.r1">[1]</xref><xref ref-type="bibr" rid="article-25623.r13">[14]</xref><xref ref-type="bibr" rid="article-25623.r14">[15]</xref></p>
        <p>
<bold>Outcomes</bold>
</p>
        <p>Necrotizing fasciitis is a serious disorder that carries a mortality rate of anywhere from 30 to 90%. The mortality ultimately depends on the patient's age, type of organism, the speed of diagnosis and treatment, and patient comorbidity. The worst prognosis is in patients with specific streptococcal strains. Other factors that adversely affect prognosis include loss of consciousness, respiratory distress, renal failure, and ARDs. Survival is best for patients with immediate radical debridement, hydration, and broad-spectrum&#x000a0;antibiotics. Even after treatment, survivors of the disorder tend to&#x000a0;have a shorter lifespan than age-matched&#x000a0;controls.<xref ref-type="bibr" rid="article-25623.r15">[16]</xref><xref ref-type="bibr" rid="article-25623.r16">[17]</xref></p>
      </sec>
      <sec id="article-25623.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25623&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25623">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/necrotizing-fasciitis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25623">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25623/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25623">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-25623.s16">
        <fig id="article-25623.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Necrotizing Fasciitis. The appearance of the lower leg after serial debridements of skin and fascia. Contributed by MA Dreyer, DPM, FACFAS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Necrotizing__Fasciitis__" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-25623.s17">
        <title>References</title>
        <ref id="article-25623.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Ha</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SW</given-names>
              </name>
            </person-group>
            <article-title>Managing necrotising fasciitis to reduce mortality and increase limb salvage.</article-title>
            <source>J Wound Care</source>
            <year>2018</year>
            <month>Sep</month>
            <day>01</day>
            <volume>27</volume>
            <issue>Sup9a</issue>
            <fpage>S20</fpage>
            <page-range>S20-S27</page-range>
            <pub-id pub-id-type="pmid">30207851</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25623.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lange</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Cegolon</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Comment on: Early clinical manifestations of vibrio necrotising fasciitis.</article-title>
            <source>Singapore Med J</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>59</volume>
            <issue>8</issue>
            <fpage>449</fpage>
            <pub-id pub-id-type="pmid">30175372</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25623.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heijkoop</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Parker</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Spernat</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Fournier's gangrene: not as lethal as previously thought? A case series.</article-title>
            <source>ANZ J Surg</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>89</volume>
            <issue>4</issue>
            <fpage>350</fpage>
            <page-range>350-352</page-range>
            <pub-id pub-id-type="pmid">30173412</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25623.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Erichsen Andersson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Egerod</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Knudsen</surname>
                <given-names>VE</given-names>
              </name>
              <name>
                <surname>Fagerdahl</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Signs, symptoms and diagnosis of necrotizing fasciitis experienced by survivors and family: a qualitative Nordic multi-center study.</article-title>
            <source>BMC Infect Dis</source>
            <year>2018</year>
            <month>Aug</month>
            <day>28</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>429</fpage>
            <pub-id pub-id-type="pmid">30153808</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25623.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khalid</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Junejo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mir</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Invasive Community Acquired Methicillin-Resistant Staphylococcal Aureus (CA-MRSA) Infections in Children.</article-title>
            <source>J Coll Physicians Surg Pak</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>28</volume>
            <issue>9</issue>
            <fpage>S174</fpage>
            <page-range>S174-S177</page-range>
            <pub-id pub-id-type="pmid">30173689</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25623.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fernando</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Tran</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Rochwerg</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kyeremanteng</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Seely</surname>
                <given-names>AJE</given-names>
              </name>
              <name>
                <surname>Inaba</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Necrotizing Soft Tissue Infection: Diagnostic Accuracy of Physical Examination, Imaging, and LRINEC Score: A Systematic Review and Meta-Analysis.</article-title>
            <source>Ann Surg</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>269</volume>
            <issue>1</issue>
            <fpage>58</fpage>
            <page-range>58-65</page-range>
            <pub-id pub-id-type="pmid">29672405</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25623.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fais</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Viero</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Viel</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Giordano</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Raniero</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kusstatscher</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Giraudo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cecchetto</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Montisci</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Necrotizing fasciitis: case series and review of the literature on clinical and medico-legal diagnostic challenges.</article-title>
            <source>Int J Legal Med</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>132</volume>
            <issue>5</issue>
            <fpage>1357</fpage>
            <page-range>1357-1366</page-range>
            <pub-id pub-id-type="pmid">29627916</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25623.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ya&#x0015f;ar</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Uyla&#x0015f;</surname>
                <given-names>MU</given-names>
              </name>
              <name>
                <surname>Badak</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bilge</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>&#x000d6;ner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>&#x00130;htiyar</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>&#x000c7;a&#x0011f;a</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Pa&#x0015f;ao&#x0011f;lu</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Can we predict mortality in patients with necrotizing fasciitis using conventional scoring systems?</article-title>
            <source>Ulus Travma Acil Cerrahi Derg</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>23</volume>
            <issue>5</issue>
            <fpage>383</fpage>
            <page-range>383-388</page-range>
            <pub-id pub-id-type="pmid">29052823</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25623.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ballesteros-Betancourt</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Tarri&#x000f1;o</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>R&#x000ed;os-Guillermo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rodriguez-Roiz</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Camacho</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zumbado-Dijeres</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Domingo-Trepat</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Llus&#x000e1;-P&#x000e9;rez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Combalia-Aleu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Ramiro</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Soriano-Viladomiu</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Necrotizing fasciitis attended in the Emergency Department in a tertiary Hospital: Evaluation of the LRINEC scale.</article-title>
            <source>Rev Esp Cir Ortop Traumatol</source>
            <year>2017</year>
            <season>Jul-Aug</season>
            <volume>61</volume>
            <issue>4</issue>
            <fpage>265</fpage>
            <page-range>265-272</page-range>
            <pub-id pub-id-type="pmid">28641951</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25623.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonne</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Kadri</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Evaluation and Management of Necrotizing Soft Tissue Infections.</article-title>
            <source>Infect Dis Clin North Am</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>497</fpage>
            <page-range>497-511</page-range>
            <pub-id pub-id-type="pmid">28779832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25623.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Semeni&#x0010d;</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kolar</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Fournier's Gangrene Does Not Spare Young Adults.</article-title>
            <source>Wounds</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>30</volume>
            <issue>7</issue>
            <fpage>E73</fpage>
            <page-range>E73-E76</page-range>
            <pub-id pub-id-type="pmid">30059341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25623.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abass-Shereef</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kovacs</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>EL</given-names>
              </name>
            </person-group>
            <article-title>Fournier's Gangrene Masking as Perineal and Scrotal Cellulitis.</article-title>
            <source>Am J Emerg Med</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>36</volume>
            <issue>9</issue>
            <fpage>1719.e1</fpage>
            <page-range>1719.e1-1719.e2</page-range>
            <pub-id pub-id-type="pmid">30041909</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25623.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baraket</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Triki</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ayed</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hmida</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Lahmidi</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Baccar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bouchoucha</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>[Therapeutic factors affecting the healing process in patients with gangrene of the perineum].</article-title>
            <source>Pan Afr Med J</source>
            <year>2018</year>
            <volume>29</volume>
            <fpage>70</fpage>
            <pub-id pub-id-type="pmid">29875951</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25623.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ioannidis</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Kitsikosta</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tatsis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Skandalos</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Cheva</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gkioti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Varnalidis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Symeonidis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Savvala</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Parpoudi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Paraskevas</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Pramateftakis</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Kotidis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mantzoros</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Tsalis</surname>
                <given-names>KG</given-names>
              </name>
            </person-group>
            <article-title>Fournier's Gangrene: Lessons Learned from Multimodal and Multidisciplinary Management of Perineal Necrotizing Fasciitis.</article-title>
            <source>Front Surg</source>
            <year>2017</year>
            <volume>4</volume>
            <fpage>36</fpage>
            <pub-id pub-id-type="pmid">28740847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25623.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ray-Zack</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Hernandez</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Younis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hoch</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Soukup</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Haddad</surname>
                <given-names>NN</given-names>
              </name>
              <name>
                <surname>Zielinski</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Validation of the American Association for the Surgery of Trauma emergency general surgery grade for skin and soft tissue infection.</article-title>
            <source>J Trauma Acute Care Surg</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>84</volume>
            <issue>6</issue>
            <fpage>939</fpage>
            <page-range>939-945</page-range>
            <pub-id pub-id-type="pmid">29794690</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25623.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gawaziuk</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Strazar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cristall</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Logsetty</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Factors predicting health-related quality of life following necrotizing fasciitis.</article-title>
            <source>J Plast Reconstr Aesthet Surg</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>71</volume>
            <issue>6</issue>
            <fpage>857</fpage>
            <page-range>857-862</page-range>
            <pub-id pub-id-type="pmid">29503165</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
